» Articles » PMID: 15728984

Prevalence of Hepatitis B Infection in the Southeastern Region of Turkey: Comparison of Risk Factors for HBV Infection in Rural and Urban Areas

Overview
Date 2005 Feb 25
PMID 15728984
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Although hepatitis B has been well studied, there are still aspects of its epidemiology that remain to be clarified. There are many regions with high seroprevalence, particularly in the developing regions of the world, and these regions are known to have different epidemiologic patterns. Nonetheless, there are currently no data on the differences in hepatitis B seroprevalence between urban and rural areas of Turkey. In the present study, therefore, we used 30-cluster sampling to determine and compare the prevalence of hepatitis B in the urban and rural areas of the least developed region of Turkey, the southeastern region. From 2,888 adults living in the region, blood samples were obtained from house visits, and screened for HBsAg, anti-HBs, and anti-HBcIgG. Factors associated with hepatitis B seroprevalence, particularly living in rural areas, were analyzed with multivariate methods. The seroprevalence of HBsAg was 8.2% in the rural and 6.2% in the urban areas. There was a statistically significant difference between urban and rural regions in terms of HBsAg positivity (crude OR: 0.74; 95% CI: 0.55 - 0.98). Exposure to hepatitis B virus (HBV) increased with age both in urban and rural areas. Lower education level was also an important risk factor for hepatitis B seropositivity in urban areas (adjusted OR: 1.66; 95% CI: 1.26 - 2.19) but not in rural ones (adjusted OR: 0.77; 95% CI: 0.36 - 1.69). Familial jaundice history was a statistically significant risk factor for HBsAg positivity in rural areas (adjusted OR: 2.15; 95% CI: 1.30 - 3.56) but not in urban ones (adjusted OR: 1.48; 95% CI: 0.96 - 2.27). This study shows that the prevalence of HBV infection in the southeastern region of Turkey is intermediate among the levels reported for the European region of the World Health Organization.

Citing Articles

Sero-prevalence of hepatitis B and C and HIV among students at the Federal University of Health Sciences, Azare.

Garbati M, Mohammed A, Kadaura M, Ezenkwa U, Audu B Niger Med J. 2025; 65(6):1112-1123.

PMID: 39877516 PMC: 11770648. DOI: 10.60787/nmj.v65i6.596.


Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case-Control Study.

Weldebrhan D, Berhe H, Tesfay Y Hepat Med. 2023; 15:79-91.

PMID: 37489134 PMC: 10363344. DOI: 10.2147/HMER.S407069.


A cross-sectional study on the prevalence of HIV and hepatitis B virus co-infection among students of a tertiary institution in Ekiti State, Southwest Nigeria.

Ojerinde O, Ojo S, Udewena U, Oladeji S Pan Afr Med J. 2023; 44:7.

PMID: 36818031 PMC: 9935660. DOI: 10.11604/pamj.2023.44.7.31416.


Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia.

Teame G, Gebreyesus A, Tsegay E, Gebretsadik M, Adane K AIDS Res Ther. 2022; 19(1):57.

PMID: 36457041 PMC: 9714192. DOI: 10.1186/s12981-022-00479-8.


Simultaneous Detection of Ochratoxin A and Aflatoxins in Industrial and Traditional Red and Pepper Flakes along with Dietary Exposure Risk Assessment.

Oztekin S, Karbancioglu-Guler F ACS Omega. 2022; 7(36):31756-31766.

PMID: 36120009 PMC: 9476180. DOI: 10.1021/acsomega.2c02236.